Seres’ ulcerative colitis candidate misses primary endpoint in mid-stage study
23rd July 2021 Uncategorised 0Microbiome-based therapeutic failed to improve clinical remission rates among mild-to-moderate ulcerative colitis patients
More: Seres’ ulcerative colitis candidate misses primary endpoint in mid-stage study
Source: News